Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-09 Sale | 2024-01-10 4:30 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 11,271 | $4.38 | $49,367 | 158,069 (Direct) | View |
| 2023-01-10 Sale | 2023-01-11 4:08 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 10,917 | $5.24 | $57,205 | 168,917 (Direct) | View |
| 2022-07-07 Sale | 2022-07-08 4:51 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 17,158 | $30.23 | $518,686 | 192,990 (Direct) | View |
| 2022-07-06 Sale | 2022-07-07 4:04 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 7,842 | $30.07 | $235,809 | 218,852 (Direct) | View |
| 2022-03-14 Sale | 2022-03-15 4:27 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 25,000 | $31.07 | $776,733 | 215,990 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 4:07 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 4,570 | $48.5 | $221,655 | 146,532 (Direct) | View |
| 2022-01-10 Sale | 2022-01-12 4:05 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 5,596 | $46.38 | $259,558 | 151,102 (Direct) | View |
| 2021-12-13 Sale | 2021-12-14 4:18 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 25,000 | $47.66 | $1,191,406 | 217,854 (Direct) | View |
| 2021-09-13 Sale | 2021-09-14 4:01 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $66.29 | $1,657,257 | 181,896 (Direct) | View |
| 2021-06-14 Sale | 2021-06-16 4:26 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $89.32 | $2,233,045 | 206,896 (Direct) | View |
| 2021-03-15 Sale | 2021-03-16 4:05 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $92.35 | $2,308,772 | 111,896 (Direct) | View |
| 2021-01-08 Sale | 2021-01-12 8:40 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 9,484 | $114.95 | $1,090,140 | 77,727 (Direct) | View |
| 2020-12-14 Sale | 2020-12-15 4:01 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $97.78 | $2,444,477 | 128,367 (Direct) | View |
| 2020-09-14 Sale | 2020-09-16 4:02 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $36.28 | $907,024 | 153,367 (Direct) | View |
| 2020-01-08 Sale | 2020-01-10 4:03 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 5,700 | $20.69 | $117,947 | 176,058 (Direct) | View |
| 2019-10-15 Sale | 2019-10-16 4:06 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 6,200 | $14.18 | $87,891 | 66,758 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-02 4:09 pm | N/A 2034-01-31 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-07 4:20 pm | N/A 2033-02-05 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-01-12 Exercise | 2023-01-13 4:02 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 423 | $1.37 | 169,340 (Direct) | View |
| 2023-01-12 Exercise | 2023-01-13 4:02 pm | N/A 2023-01-14 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 423 | $0 | 169,340 (Direct) | View |
| 2022-07-07 Exercise | 2022-07-08 4:51 pm | N/A 2027-01-04 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 17,158 | $2.73 | 192,990 (Direct) | View |
| 2022-07-06 Exercise | 2022-07-07 4:04 pm | N/A 2025-01-05 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 2,000 | $4.84 | 218,852 (Direct) | View |
| 2022-07-06 Exercise | 2022-07-07 4:04 pm | N/A 2027-01-04 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 5,842 | $2.73 | 218,852 (Direct) | View |
| 2022-03-14 Exercise | 2022-03-15 4:27 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 25,000 | $2.73 | 215,990 (Direct) | View |
| 2022-03-14 Exercise | 2022-03-15 4:27 pm | N/A 2027-01-04 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 25,000 | $0 | 215,990 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:38 pm | N/A 2032-01-24 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram See Remarks | 86,360 | $0 | 232,892 (Direct) | View |
| 2021-12-13 Exercise | 2021-12-14 4:18 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 25,000 | $2.73 | 217,854 (Direct) | View |
| 2021-12-13 Exercise | 2021-12-14 4:18 pm | N/A 2027-01-04 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 25,000 | $0 | 217,854 (Direct) | View |
| 2021-11-19 Option Award | 2021-11-22 5:44 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer | 60,958 | $0 | 156,698 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-14 4:01 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $2.73 | 181,896 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-14 4:01 pm | N/A 2027-01-04 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $0 | 181,896 (Direct) | View |
| 2021-06-14 Exercise | 2021-06-16 4:26 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 8,844 | $2.73 | 206,896 (Direct) | View |
| 2021-06-14 Exercise | 2021-06-16 4:26 pm | N/A 2026-01-08 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $0 | 206,896 (Direct) | View |
| 2021-06-14 Exercise | 2021-06-16 4:26 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 16,156 | $2.9 | 206,896 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-16 4:05 pm | N/A 2026-01-07 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $0 | 111,896 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-16 4:05 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $2.9 | 111,896 (Direct) | View |
| 2021-01-20 Option Award | 2021-01-22 6:22 pm | N/A 2031-01-20 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 24,864 | $0 | 102,591 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-15 4:01 pm | N/A 2026-01-07 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $0 | 128,367 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-15 4:01 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $2.9 | 128,367 (Direct) | View |
| 2020-09-14 Exercise | 2020-09-16 4:02 pm | N/A 2021-03-11 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 25,000 | $0 | 153,367 (Direct) | View |
| 2020-09-14 Exercise | 2020-09-16 4:02 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 3,076 | $1.69 | 153,367 (Direct) | View |
| 2020-09-14 Exercise | 2020-09-16 4:02 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 21,924 | $2.9 | 153,367 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 4:01 pm | N/A 2020-02-10 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 1,153 | $0 | 87,211 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 4:01 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 1,153 | $1.69 | 87,211 (Direct) | View |
| 2020-01-08 Option Award | 2020-01-10 4:03 pm | N/A 2030-01-08 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer | 115,000 | $0 | 176,058 (Direct) | View |